Vanda Pharmaceuticals Inc. VNDA
$5.22
+3.78%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $13.70
- Implied Upside
- +162.5%
- Price Target Range
- $7.50 – $20.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-10 | B. Riley SecuritiesMadison El-Saadi |
Reiterates | Buy | $17 → $12 |
| 2026-08-10 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $21 → $20 |
| 2026-05-11 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $24 → $21 |
| 2026-03-05 | Truist SecuritiesLes Sulewski |
Initiates coverage on | Buy | $18 |
| 2026-02-23 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $22 → $24 |
| 2026-01-05 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $20 → $22 |
| 2025-12-31 | B. Riley SecuritiesMadison El-Saadi |
Maintains | Buy | $11 → $14 |
| 2025-12-31 | JefferiesChris Howerton |
Maintains | Hold | $5 → $8 |
| 2025-11-19 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $20 |
| 2025-11-05 | B. Riley SecuritiesMadison El-Saadi |
Initiates coverage on | Buy | $11 |
| 2025-10-30 | Cantor FitzgeraldOlivia Brayer |
Maintains | Overweight | $13 → $11 |
| 2025-08-21 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $20 |
| 2025-05-14 | Cantor FitzgeraldOlivia Brayer |
Assumes | Overweight | $13 |
| 2025-05-07 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $20 |
| 2025-04-01 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $20 |
| 2025-02-18 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $18 → $20 |
| 2025-02-04 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $18 |
| 2025-01-28 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $18 |
| 2025-01-21 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $18 |
| 2024-12-23 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $18 |
| 2024-10-31 | HC Wainwright & Co.Raghuram Selvaraju |
Initiates coverage on | Buy | $18 |
| 2024-08-01 | Cantor FitzgeraldCharles Duncan |
Maintains | Overweight | $11 → $13 |
| 2024-07-11 | Cantor FitzgeraldCharles Duncan |
Initiates coverage on | Overweight | $11 |
| 2022-02-25 | JefferiesChris Howerton |
Downgrades | Buy → Hold | $24 → $12 |
| 2021-05-12 | B of A Securities |
Initiates coverage on | Buy | $22 |
| 2021-01-14 | CitigroupJoel Beatty |
Downgrades | Buy → Neutral | $14 |
| 2020-10-29 | CitigroupJoel Beatty |
Upgrades | Neutral → Buy | $14 |
| 2020-06-09 | CitigroupJoel Beatty |
Downgrades | Buy → Neutral | $14 |
| 2020-03-12 | CitigroupJoel Beatty |
Upgrades | Neutral → Buy | $14 |
| 2020-02-26 | Stifel |
Maintains | Hold | $17 → $13 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $5.22
- Market Cap
- $313.80 million
- 52-Week Range
- $4.14 – $9.94
- Average Volume
- 977K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.